These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17877651)

  • 1. Predicting coronary heart disease risk using the Framingham and PROCAM equations in dyslipidaemic patients without overt vascular disease.
    Vrentzos GE; Papadakis JA; Ganotakis ES; Paraskevas KI; Gazi IF; Tzanakis N; Nair DR; Mikhailidis DP
    Int J Clin Pract; 2007 Oct; 61(10):1643-53. PubMed ID: 17877651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation.
    Ferrario M; Chiodini P; Chambless LE; Cesana G; Vanuzzo D; Panico S; Sega R; Pilotto L; Palmieri L; Giampaoli S;
    Int J Epidemiol; 2005 Apr; 34(2):413-21. PubMed ID: 15659467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of serum lipid level change on 10-year coronary heart risk distribution estimated by means of seven different coronary risk scores during one-year treatment.
    Kojić NE; Derić M; Dejanović J
    Med Pregl; 2014; 67(7-8):208-15. PubMed ID: 25151760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM).
    Dunder K; Lind L; Zethelius B; Berglund L; Lithell H
    Am Heart J; 2004 Oct; 148(4):596-601. PubMed ID: 15459588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary heart disease risk assessment in HIV-infected patients: a comparison of Framingham, PROCAM and SCORE risk assessment functions.
    Moreira Guimarães MM; Bartolomeu Greco D; Ingles Garces AH; de Oliveira AR; Bastos Fóscolo R; de Campos Machado LJ
    Int J Clin Pract; 2010 May; 64(6):739-45. PubMed ID: 20518949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.
    Buyken AE; von Eckardstein A; Schulte H; Cullen P; Assmann G
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):230-6. PubMed ID: 17446801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study.
    Cooper JA; Miller GJ; Humphries SE
    Atherosclerosis; 2005 Jul; 181(1):93-100. PubMed ID: 15939059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk factors and endothelial dysfunction.
    Wierzbicki AS; Chowienczyk PJ; Cockcroft JR; Brett SE; Watts GF; Jenkins BS; Ritter JM
    Clin Sci (Lond); 2004 Dec; 107(6):609-15. PubMed ID: 15450002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of cardiovascular risk scores in a liver transplant population.
    Guckelberger O; Mutzke F; Glanemann M; Neumann UP; Jonas S; Neuhaus R; Neuhaus P; Langrehr JM
    Liver Transpl; 2006 Mar; 12(3):394-401. PubMed ID: 16498651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the performance of the Framingham risk equations in a population with diabetes.
    McEwan P; Williams JE; Griffiths JD; Bagust A; Peters JR; Hopkinson P; Currie CJ
    Diabet Med; 2004 Apr; 21(4):318-23. PubMed ID: 15049932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Framingham Coronary Heart Disease Risk Score in dementia caregivers relative to non-caregiving controls.
    von Känel R; Mausbach BT; Patterson TL; Dimsdale JE; Aschbacher K; Mills PJ; Ziegler MG; Ancoli-Israel S; Grant I
    Gerontology; 2008; 54(3):131-7. PubMed ID: 18204247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen, lipoprotein (a), albumin and bilirubin (F-L-A-B) levels and cardiovascular risk calculated using the Framingham equation.
    Ganotakis ES; Vrentzos GE; Gazi IF; Papadakis JA; Jagroop A; Paraskevas KI; Nair DR; Mikhailidis DP
    In Vivo; 2007; 21(4):685-94. PubMed ID: 17708367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shrinking cardiovascular risk through bariatric surgery: application of Framingham risk score in gastric bypass.
    Kligman MD; Dexter DJ; Omer S; Park AE
    Surgery; 2008 Apr; 143(4):533-8. PubMed ID: 18374051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of strategy for the management of overt dyslipidemia: the IMPROVE-dyslipidemia study.
    Hatzitolios AI; Athyros VG; Karagiannis A; Savopoulos C; Charalambous C; Kyriakidis G; Milidis T; Papathanakis C; Bitli A; Vogiatsis I; Ntaios G; Katsiki N; Symeonidis A; Tziomalos K; Mikhailidis DP;
    Int J Cardiol; 2009 May; 134(3):322-9. PubMed ID: 19268376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study.
    Assmann G; Schulte H; Seedorf U
    Int J Obes (Lond); 2008 May; 32 Suppl 2():S11-6. PubMed ID: 18469834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nurse-led risk assessment/management clinics reduce predicted cardiac morbidity and mortality in claudicants.
    Hatfield J; Gulati S; Abdul Rahman MN; Coughlin PA; Chetter IC
    J Vasc Nurs; 2008 Dec; 26(4):118-22. PubMed ID: 19022170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Münster (PROCAM) study.
    Assmann G; Schulte H; Cullen P; Seedorf U
    Eur J Clin Invest; 2007 Dec; 37(12):925-32. PubMed ID: 18036028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.